Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit

References

• Jennette J. C., Falk R. J., Andrassy K., Bacon P. A., Churg J., Gross W. L., et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 31: 187–92
   Google Scholar
• Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–98
   PubMed Web of Science ®Google Scholar
• Jayne D. R. Pulmonary‐renal syndrome. Semin Resp Crit Care Med 1998; 19: 69–77
   Google Scholar
• Niles J. L., Bottinger E. P., Saurina G. R., Kelly K. J., Pan G., Collins A. B., et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA‐associated condition. Arch Intern Med 1996; 156: 440–5
   PubMed Web of Science ®Google Scholar
• Walton E. W. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958; 2: 265–70
   PubMed Web of Science ®Google Scholar
• Fauci A. S., Barton F. H., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–85
   PubMed Web of Science ®Google Scholar
• Koldingsnes W., Nossent H. Predictors of survival and organ damage in Wegener's garnulomatosis. Rheumatology 2002; 41: 572–81
   PubMed Web of Science ®Google Scholar
• Briedigkeit L., Kettritz R., Gobel O., Natusch R. Prognostic factors in Wegener's granulomatosis. Postgrad Med J 1993; 69: 856–61
   PubMedGoogle Scholar
• Luqmani R. A., Bacon P. A., Beaman M., Scott D. G., Emery P., Lee S. J., et al. Classical versus non‐renal Wegener's granulomatosis. Q J Med 1994; 87: 161–7
   PubMedGoogle Scholar
• Westman K. W., Bygren P. G., Olsson H., Ranstam J., Wieslander J. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998; 9: 842–52
   PubMed Web of Science ®Google Scholar
• Aasarod K., Iversen B. M., Hammerstrom J., Bostad L., Vatten L., Jorstad S. Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000; 15: 611–18
   PubMed Web of Science ®Google Scholar
• Reinhold‐Keller E., Beuge N., Latza U., de Groot K., Rudert H., Nolle B., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long‐term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021–32
   PubMed Web of Science ®Google Scholar
• Mahr A., Girard T., Agher R., Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow‐up. Rheumatology 2001; 40: 492–8
   PubMed Web of Science ®Google Scholar
• Bligny D., Mahr A., Toumelin P. L., Mouthon L., Guillevin L. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum 2004; 51: 83–91
   PubMed Web of Science ®Google Scholar
• Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101–7
   PubMed Web of Science ®Google Scholar
• Kollef M. H., Enzenauer R. J. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 1992; 19: 1260–2
   PubMed Web of Science ®Google Scholar
• Godeau B., Boudjadja A., Dhainaut J. F., Schlemmer B., Chastang C., Brunet F., et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 1992; 51: 627–31
   PubMedGoogle Scholar
• Godeau B., Mortier E., Roy P. M., Chevret S., Bouachour G., Schlemmer B., et al. Short‐ and long‐term outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 1997; 24: 1317–23
   PubMed Web of Science ®Google Scholar
• Thong B. Y., Tai D. Y., Goh S. K., Johan A. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 2001; 30: 254–9
   PubMed Web of Science ®Google Scholar
• Alzeer A. H., Al‐Arfaj A., Basha S. J., Alballa S., Al‐Wakeel J., Al‐Arfaj H., et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus 2004; 13: 537–42
   PubMed Web of Science ®Google Scholar
• Camargo J. F., Tobon G. J., Fonseca N., Diaz J. L., Uribe M., Molina F., et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 2005; 14: 315–20
   PubMed Web of Science ®Google Scholar
• Moreels M., Mélot C., Leeman M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 2005; 31: 591–3
   PubMed Web of Science ®Google Scholar
• Cruz B. A., Ramanoelina J., Mahr A., Cohen P., Mouthon L., Cohen Y., et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology 2003; 42: 1183–8
   PubMed Web of Science ®Google Scholar
• Lauter J. Stable Decisions in Discriminant, Regression and Factor Analysis. Model Oriented Data Analysis. Lecture Notes in Economics and Mathematical Systems 297, V Fedorov , H Lauter. Springer, Berlin 1987; 181–88
   Google Scholar
• Loh W. L. Linear discrimination with adaptive ridge classification rules. J Multivar Anal 1997; 62: 169–80
   Web of Science ®Google Scholar
• Oh T. E., Hutchinson R., Short S., Buckley T., Lin E., Leung D. Verification of the Acute Physiology and Chronic Health Evaluation scoring system in a Hong Kong intensive care unit. Crit Care Med 1993; 21: 698–705
   PubMed Web of Science ®Google Scholar
• Wong D. T., Crofts S. L., Gomez M., McGuire G. P., Byrick R. J. Evaluation of predictive ability of APACHE II system and hospital outcome in Canadian intensive care unit patients. Crit Care Med 1995; 23: 1177–83
   PubMed Web of Science ®Google Scholar
• King D. A., Codish S., Novack V., Barski L., Almog Y. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care 2005; 9: 390–5
   PubMedGoogle Scholar
• Guillevin L., Cordier J. F., Lhote F., Cohen P., Jarrousse B., Royer I., et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40: 2187–98
   PubMed Web of Science ®Google Scholar
• Langford C. A., Talar‐Williams C., Barron K. S., Sneller M. C. Use of a cyclophosphamide‐induction methotrexate‐maintenance regimen for the treatment of Wegener's granulomatosis: extended follow‐up and rate of relapse. Am J Med 2003; 114: 463–9
   PubMed Web of Science ®Google Scholar